中国兽医学报2024,Vol.44Issue(6) :1248-1255.DOI:10.16303/j.cnki.1005-4545.2024.06.20

烯丙孕素缓释片的制备及其含量测定

Preparation and content determination of extended-release tablets of altrenogest

霍雨柔 赵琪 王凯 张剑旭 徐诗瑶 张嘉斌 杨玉洁 顾海泉 李乾学 何秀霞
中国兽医学报2024,Vol.44Issue(6) :1248-1255.DOI:10.16303/j.cnki.1005-4545.2024.06.20

烯丙孕素缓释片的制备及其含量测定

Preparation and content determination of extended-release tablets of altrenogest

霍雨柔 1赵琪 1王凯 2张剑旭 2徐诗瑶 3张嘉斌 4杨玉洁 1顾海泉 5李乾学 2何秀霞6
扫码查看

作者信息

  • 1. 长春理工大学生命科学技术学院,吉林长春 130022;中国农业科学院长春兽医研究所,吉林长春 130122
  • 2. 中国农业科学院长春兽医研究所,吉林长春 130122
  • 3. 通化师范学院生命科学学院,吉林通化 134002
  • 4. 中国农业科学院长春兽医研究所,吉林长春 130122;吉林农业大学动物医学院,吉林长春 130118
  • 5. 中国农业科学院长春兽医研究所,吉林长春 130122;长春工业大学化学工程学院,吉林长春 130012
  • 6. 长春理工大学生命科学技术学院,吉林长春 130022
  • 折叠

摘要

制备烯丙孕素缓释片,对其进行质量评价并建立含量测定方法.以烯丙孕素缓释片的亲水凝胶骨架种类,用量以及片芯厚度作为考察因素,以缓释片的释放度为考察指标,对烯丙孕素缓释片的处方工艺进行单因素筛选和中心组合设计响应面法优化并进行质量评价,建立体外释药模型及建立烯丙孕素缓释片的高效液相色谱检测方法.烯丙孕素缓释片的最佳处方为:烯丙孕素2%,羟丙基-β-环糊精70%,硬酯酸镁0.5%,微晶纤维素19.1%,卡波姆B 8.4%,片厚3.8 mm.体外释药符合Higuchi模型,烯丙孕素在10~80 mg/L之间呈现良好线性关系R2=0.999 98.优化所得烯丙孕素缓释片工艺稳定,具有显著缓释效果.所建立高效液相色谱法准确可靠,可用于检测缓释片中烯丙孕素含量.

Abstract

This study aims to prepare altrenogest extended-release tablets,evaluate their quality and establish a content determination method.The hydrophilic gel skeleton type,dosage and core thick-ness of altrenogest extended-release tablets were used as the investigating factors,and the release degree of the tablets was used as the investigating index,the prescription process of altrenogest ex-tended-release tablets was optimized by one-factor screening and central combinatorial design re-sponse surface method,and quality evaluation was carried out,the in vitro release model was es-tablished,and a high-performance liquid chromatography(HPLC)assay method was set up for the determination of altrenogest extended-release tablets.The results showed that the optimal pre-scription of altrenogest extended-release tablets was 2%as the main drug,70%as the solubilizer,0.5%as the lubricant,19.1%as the filler,8.4%as the hydrophilic gel skeleton material,and the thickness of the tablets was 3.8 mm.The in vitro drug release conformed to the Higuchi model,and the altrenogest showed a good linear relationship with the R2=0.999 98 in the range of 10-80 mg/L.The optimized process for the extended-release tablets was stable and had a good quality.The extended-release tablets were stable and had significant slow-release effect.The HPLC method is accurate and reliable and can be used for the determination of altrenogest in extended-release tablets.

关键词

烯丙孕素/缓释片/中心组合设计响应面法

Key words

altrenogest/extended-release tablets/response surface methodology for central combina-tion design

引用本文复制引用

基金项目

国家自然科学基金(32001004)

国家自然科学基金(31902224)

出版年

2024
中国兽医学报
吉林大学

中国兽医学报

CSTPCD北大核心
影响因子:0.702
ISSN:1005-4545
段落导航相关论文